Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00386477 · ClinicalTrials.gov registry record · NA
Vaginal Cleansing at Cesarean Delivery to Reduce Infection: A Randomized, Controlled Trial
A NA study, sponsored by Indiana University.
- Terminated
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT00386477: Clinical Trial NA study, sponsored by Indiana University.
NCT00386477 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00386477, a NA study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
The objective of the project is to find out whether cleansing the vagina before a cesarean delivery decreases the risk of complications and infections after having the baby. If this is the case, cleansing the vagina before cesarean delivery can help improve outcomes for many women and make their early postpartum recovery much more pleasant, giving a healthier start for the family.
Primary Outcome
Endometritis was diagnosed clinically as uterine pain and fever requireing antibiotics. Wound complications included wound infection, seroma, hematoma, or separation.
Interventions
- PROCEDURE Vaginal cleansing before cesarean delivery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2006-09 |
| Est. Completion | 2009-05 |
| Phase | NA |
Why NCT00386477 stopped before completion
NCT00386477 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 1 intervention - of which Vaginal cleansing before cesarean delivery is the first listed.
NCT00386477 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00386477 about?
NCT00386477 is a clinical study titled "Vaginal Cleansing at Cesarean Delivery to Reduce Infection: A Randomized, Controlled Trial". The objective of the project is to find out whether cleansing the vagina before a cesarean delivery decreases the risk of complications and infections after having the baby. If this is the case, cleansing the vagina before cesarean delivery can help improve outcomes for many women and make their ear...
What is the current status of trial NCT00386477?
This trial is currently terminated. It is a NA study. The enrollment target is 300 participants. The study started on 2006-09. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00386477?
The interventions under investigation include: Vaginal cleansing before cesarean delivery (PROCEDURE).
Who is sponsoring clinical trial NCT00386477?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00386477's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia